Clinical Trials Directory

Trials / Completed

CompletedNCT01964001

The Effects of Vitamin B-6 and Coenzyme Q10 Status on Oxidative Stress, Antioxidant Capacities, and Inflammatory Responses in Patients With Liver Cancer

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
71 (actual)
Sponsor
Taichung Veterans General Hospital · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Carcinoma is the leading cause of worldwide. Hepatocellular carcinoma (HCC) is the second cause of cancer mortality in Taiwan. Vitamin B-6 and coenzyme Q10 has been recognized as antioxidants and anti-inflammatory nutrients in recent clinical studies. The purposes of this study are going to investigate the relation of vitamin B-6 and coenzyme Q10 with the indicators of oxidative stress, antioxidant enzymes activities and the inflammatory markers in patients with stage 1 and stage 2 HCC. The study is designed as an intervention study. The investigators will recruit HCC patients with stage 1 and stage 2 (n = 150) who are identified by liver biopsy. HCC subjects are randomly assign to placebo, vitamin B-6 (50 mg/d), coenzyme Q10 (300 mg/d), and vitamin B-6 plus coenzyme Q10 supplements groups. Intervention is going to administration for three months. The concentrations of vitamin B-6, coenzyme Q10, oxidative stress indicators, antioxidant enzymes activities, antioxidant vitamins (vitamin A and E), and inflammatory markers are going to be analyzed. The results would provide more information nutrients for clinical physicians and dietitians for considering suggesting patients with HCC using vitamin B-6 or coenzyme Q10 supplementation to improve their clinical outcomes.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin B-6Vitamin B-6 50 mg/d
DIETARY_SUPPLEMENTCoenzyme Q10Coenzyme Q10 300 mg
DIETARY_SUPPLEMENTVitamin B-6+Coenzyme Q10Vitamin B-6 (50 mg/d) and Coenzyme Q10 (300 mg/d)
OTHERPlacebostarch

Timeline

Start date
2014-01-01
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2013-10-17
Last updated
2016-06-15

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01964001. Inclusion in this directory is not an endorsement.